Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cannabinoids.

Franjo Grotenhermen1

  • 1Nova-Institut, Goldenbergstrasse 2, D-50354 Hürth, Germany. franjo.grotenhermen@nova-institut.de

Current Drug Targets. CNS and Neurological Disorders
|November 4, 2005
PubMed
Summary
This summary is machine-generated.

The endogenous cannabinoid system, involving receptors and ligands like anandamide, offers therapeutic potential. Research explores cannabinoid agonists for pain and neurological disorders, and antagonists for addiction and obesity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany.

Pharmacopsychiatry·2024
Same author

Case in Context: Acne Inversa (Hidradenitis Suppurativa).

Cannabis and cannabinoid research·2023
Same author

Case in Context: Hyperhidrosis.

Cannabis and cannabinoid research·2023
Same author

[Cannabis and cancer].

MMW Fortschritte der Medizin·2022
Same author

Franjo Grotenhermen.

Medical cannabis and cannabinoids·2021
Same author

Two Decades of the International Association for Cannabinoid Medicines: 20 Years of Supporting Research and Activities Toward the Medicinal Use of Cannabis and Cannabinoids.

Cannabis and cannabinoid research·2021

Area of Science:

  • Pharmacology and Neuroscience
  • Endocannabinoid System Research

Background:

  • The discovery of the endogenous cannabinoid system has spurred significant research into cannabinoid pharmacology and therapeutic applications.
  • Two primary G-protein coupled cannabinoid receptors, CB1 and CB2, have been identified, along with key endocannabinoids such as anandamide and 2-AG.

Purpose of the Study:

  • To review the pharmacology and therapeutic potential of cannabinoids and their modulators.
  • To explore the distribution and functions of cannabinoid receptors in the central nervous system and peripheral tissues.
  • To highlight current clinical research focuses and potential future applications of cannabinoid-based therapies.

Main Methods:

  • Literature review of research on cannabinoid receptors, endocannabinoids, and synthetic modulators.

Related Experiment Videos

  • Analysis of preclinical and clinical studies investigating the effects of cannabinoid agonists and antagonists.
  • Examination of the distribution and physiological roles of cannabinoid receptors.

    • Main Results:

    • Cannabinoid receptors are widespread in the CNS and peripheral tissues, influencing various physiological processes.
    • CB receptor agonists exhibit properties like analgesia, anti-inflammation, neuroprotection, and antiemesis, with current focus on chronic pain and neurological disorders.
    • CB receptor antagonists are being investigated for obesity and nicotine addiction, with potential for other dependencies and neurological conditions.

    Conclusions:

    • The cannabinoid system presents diverse therapeutic opportunities, from pain management and neurological disorder treatment to addiction and metabolic conditions.
    • Further research into receptor-dependent and non-receptor-dependent mechanisms, including vanilloid receptor interactions, is crucial for optimizing cannabinoid therapies.
    • Modulators of the cannabinoid system, including phytocannabinoids, endocannabinoids, synthetic agonists, and antagonists, offer a broad spectrum of potential medical applications.